Novel pharmaceutical composition

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Kabivitrum Ab patent solves the following problem:

Emepronium, with structural formula ## str1 ## is a known therapeutically active substance that is mainly used in the form of bromide. The preparation as described in Chemical Abstracts 48, 729 (1954). It is used as an anticholinergic and antispasmodic agent, mainly in the treatment of diseases related to renal function in men, for example incontinence, urinary frequency, irritable bladder, nervous bladder, and neurogenic bladder.

Our analysis of this patent is as follows:

Kabivitrum Ab’s patent US 4536495 A deals with Novel pharmaceutical composition.
A new complex of carrageenan and a member of the group consisting of emepronium, doxycycline and propranolol, pharmaceutical preparations containing such a complex, and its use in medicine.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.